» Articles » PMID: 22308515

Senior Adult Oncology

Citing Articles

An Annual Symposium on Disparities in Milwaukee, WI, with a 2023 Focus on Older Adults with Cancer.

Kamaraju S, McKoy J, Williams G, Gilmore N, Minami C, Bylow K Curr Oncol Rep. 2024; 26(8):855-864.

PMID: 38801612 PMC: 11300154. DOI: 10.1007/s11912-024-01525-6.


Anemia in patients ≥ 75 years with metastatic clear cell renal cell carcinoma: an important poor prognostic factor in the international metastatic renal cell carcinoma database consortium model.

Mizuno R, Yasumizu Y, Tanaka N, Takeda T, Morita S, Matsumoto K BMC Urol. 2024; 24(1):13.

PMID: 38212721 PMC: 10782570. DOI: 10.1186/s12894-024-01403-0.


Best Possible Medication History Collection by Clinical Pharmacist in a Preoperative Setting: An Observational Prospective Study.

Mengato D, Pivato L, Codato L, Faccioli F, Camuffo L, Giron M Pharmacy (Basel). 2023; 11(5).

PMID: 37736914 PMC: 10514880. DOI: 10.3390/pharmacy11050142.


Changes in physical function in older women with endometrial cancer with or without adjuvant therapy.

Quick A, McLaughlin E, Krok Schoen J, Felix A, Presley C, Cespedes Feliciano E J Cancer Surviv. 2023; 19(1):206-215.

PMID: 37668940 DOI: 10.1007/s11764-023-01460-8.


Narrative Review of Multidisciplinary Management of Central Nervous Involvement in Patients with HER2-Positive Metastatic Breast Cancer: Focus on Elderly Patients.

Galve-Calvo E, Alonso-Babarro A, Martinez-Garcia M, Pi-Figueras M, Villalba G, Alonso S Adv Ther. 2023; 40(8):3304-3331.

PMID: 37291377 DOI: 10.1007/s12325-023-02538-6.


References
1.
Inouye S, van Dyck C, Alessi C, Balkin S, Siegal A, Horwitz R . Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990; 113(12):941-8. DOI: 10.7326/0003-4819-113-12-941. View

2.
Pepe C, Hasan B, Winton T, Seymour L, Graham B, Livingston R . Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. J Clin Oncol. 2007; 25(12):1553-61. DOI: 10.1200/JCO.2006.09.5570. View

3.
Mateos M, Richardson P, Schlag R, Khuageva N, Dimopoulos M, Shpilberg O . Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial. J Clin Oncol. 2010; 28(13):2259-66. DOI: 10.1200/JCO.2009.26.0638. View

4.
Hanlon J, Artz M, Pieper C, Lindblad C, Sloane R, Ruby C . Inappropriate medication use among frail elderly inpatients. Ann Pharmacother. 2004; 38(1):9-14. DOI: 10.1345/aph.1D313. View

5.
Sul J, DeAngelis L . Neurologic complications of cancer chemotherapy. Semin Oncol. 2006; 33(3):324-32. DOI: 10.1053/j.seminoncol.2006.03.006. View